Premium Nahrungsergänzungsmittel | artgerecht

Riboflavin Synthesis Analysis – Diagnostics & Significance

Riboflavin synthesis analysis examines the production and metabolism of riboflavin (vitamin B2) in the body. It helps detect deficiencies and metabolic disorders at an early stage.

Regular tips about health Regular tips about health

Things worth knowing about "Riboflavin synthesis analysis"

Riboflavin synthesis analysis examines the production and metabolism of riboflavin (vitamin B2) in the body. It helps detect deficiencies and metabolic disorders at an early stage.

What Is Riboflavin Synthesis Analysis?

Riboflavin synthesis analysis is a diagnostic procedure that evaluates the synthesis, transport, and metabolism of riboflavin (vitamin B2) in the human body. Riboflavin is an essential, water-soluble vitamin that the human organism cannot produce in sufficient quantities on its own and must therefore be obtained through diet. The analysis assesses the biochemical processes involved in the conversion of riboflavin into its active coenzyme forms – flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD).

Biological Basis of Riboflavin Synthesis

While humans cannot synthesize riboflavin independently, certain gut bacteria (e.g., Lactobacillus and Bifidobacterium species) are capable of producing riboflavin de novo. However, this microbial synthesis contributes only a small portion to the overall supply. The majority of riboflavin needed by the body is obtained through diet and subsequently converted enzymatically in the liver into FMN and FAD.

The key steps of riboflavin biotransformation include:

Phosphorylation of riboflavin to FMN by the enzyme riboflavin kinase
Conversion of FMN to FAD by FAD synthetase
Incorporation of FAD and FMN as cofactors into numerous flavoproteins involved in energy production and cellular metabolism

Methods of Riboflavin Synthesis Analysis

The analysis can be conducted at various diagnostic levels:

Blood and Urine Tests

Measurement of riboflavin levels in plasma or serum
Determination of erythrocyte glutathione reductase (EGR) activity: This is the most common functional test for assessing riboflavin status. A high activation coefficient indicates riboflavin deficiency.
Measurement of riboflavin excretion in 24-hour urine

Molecular and Genetic Analysis

Examination of mutations in genes responsible for riboflavin transport and metabolism (e.g., SLC52A1, SLC52A2, SLC52A3)
Analysis in cases of suspected rare conditions such as Brown-Vialetto-Van Laere syndrome, which is caused by a riboflavin transporter defect

Stool Analysis (Microbiome-Based)

Examination of riboflavin-synthesizing gut bacteria to assess microbial contributions to riboflavin supply

Clinical Significance and Indications

Riboflavin synthesis analysis is used in the following situations:

Suspected riboflavin deficiency (ariboflavinosis): Symptoms include angular cheilitis, glossitis, seborrheic dermatitis, and photosensitivity of the eyes
Investigation of neurological disorders, particularly when riboflavin transporter deficiency is suspected
Assessment of nutritional status in at-risk groups (pregnant women, older adults, vegans, patients with malabsorption syndromes)
Monitoring during therapies with medications that affect riboflavin metabolism (e.g., tricyclic antidepressants, certain antibiotics)
Monitoring in congenital metabolic disorders

Reference Values and Interpretation

Reference values for riboflavin status may vary depending on the analytical method and laboratory. Typical orientation values include:

Plasma riboflavin: 106–638 nmol/L (normal range)
EGR activation coefficient: below 1.2 is considered adequate; values above 1.4 indicate deficiency
Urinary excretion: more than 120 µg/day is considered sufficient

Treatment Approaches for Abnormal Results

When riboflavin deficiency or metabolic impairment is confirmed, the following measures are applied:

Dietary adjustment: Increased intake of riboflavin-rich foods such as dairy products, eggs, meat, fish, legumes, and whole grains
Supplementation: Oral or, in rare cases, intravenous administration of riboflavin preparations
High-dose therapy: In riboflavin transporter deficiency, very high doses of riboflavin (up to 10 mg/kg body weight per day) are used

References

Powers, H.J. - Riboflavin (vitamin B-2) and health. American Journal of Clinical Nutrition, 77(6):1352–1360, 2003. PubMed PMID: 12791609.
World Health Organization (WHO) & Food and Agriculture Organization of the United Nations (FAO) - Vitamin and Mineral Requirements in Human Nutrition, 2nd edition. Geneva: WHO Press, 2004.
Bosch, A.M. et al. - Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment. Journal of Inherited Metabolic Disease, 34(1):159–164, 2011. PubMed PMID: 20830494.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.